Furthermore, in order to elucidate the molecular mechanism behind the metastatic inhibitory effects of propofol in breast cancer, Li et al. [37] revealed that propofol hindered the capacity of cancer cells to invade and migrate and decreased MMP expression by decreasing NF-κB pathways. The gene discussed is NFKB1; the disease is cancer.